Essential Oil Mouthwash - Oral Hygiene
EOMOH-RCT
Efficacy of an Essential Oil-based Mouthwash in Improving Oral Hygiene Among the Elderly Community: a Randomized Clinical Trial
1 other identifier
interventional
150
1 country
1
Brief Summary
Background Inadequate oral health can further compromise general health, particularly in elderly patients who are more susceptible to tooth loss, periodontal disease, and oral infections. These conditions can impair nutrition and overall well-being and are associated with increased risks of systemic diseases, underscoring the critical need for effective oral care in this population. Essential oils and various plant extracts have attracted considerable attention as potential natural medicinal products due to their proven antibacterial, antifungal, antiviral, and antioxidant properties. However, the precise effects and underlying mechanisms through which essential oil mouthwashes promote oral health remain incompletely understood. Objective This study aims to evaluate the potential of a mouthwash formulated with a blend of tea tree, lemon, and bay laurel essential oils, which have long been recognized for their medicinal properties in alleviating inflammatory signs of intraoral mucosa and promoting both oral and gingival health, in comparison with/ without alcohol-based mouthwashes. Methods One hundred five community-dwelling elderly individuals were randomly assigned to one of three groups and used a designated mouthwash for oral care over 21 days. The study groups were as follows:
- 1.Essential oils mouthwash (tea tree, lemon, and bay laurel).
- 2.Chlorhexidine alcohol-free mouthwash.
- 3.Povidone-iodine alcohol-free mouthwash. Participants were instructed to use the assigned mouthwash for oral hygiene at least twice daily, in the morning and evening. Saliva samples were collected on day 1 (before using the mouthwash) and on day 21 to analyze oral microbiota and inflammation markers and assess oral health and the incidence of upper respiratory tract infections.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 12, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 11, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
October 12, 2026
CompletedFirst Submitted
Initial submission to the registry
October 15, 2026
CompletedFirst Posted
Study publicly available on registry
October 21, 2026
CompletedOctober 21, 2026
February 1, 2025
10 months
October 15, 2026
October 15, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in Oral Health Assessment Tool (OHAT) Score
Overall oral health status assessed by a trained assessor blinded to group allocation using the Oral Health Assessment Tool, which comprises eight domains (lips, tongue, gums and oral tissues, saliva, natural teeth, dentures, oral cleanliness, and dental pain), each scored 0-2. Total score ranges from 0 to 16; higher scores indicate poorer oral health.
Baseline (Day 1) and Day 21
Change in Plaque Index Score
Dental plaque accumulation assessed using a plaque-disclosing agent and scored by a trained assessor blinded to group allocation according to the Silness and Löe criteria: 0 = no plaque, 1 = thin film of plaque along the gingival margin, 2 = visible plaque accumulation, 3 = abundant plaque accumulation. Higher scores indicate greater plaque accumulation.
Baseline (Day 1) and Day 21
Change in Halitosis Consequences Inventory (ICH) Score
Halitosis-related quality of life assessed using the 18-item self-report Halitosis Consequences Inventory, with each item rated dichotomously for the presence (1) or absence (0) of the corresponding behavioral, emotional, or social consequence of bad breath. Total score ranges from 0 to 18; higher scores indicate greater perceived impact of halitosis.
Baseline (Day 1) and Day 21
Secondary Outcomes (6)
Change in Stomatitis Index Score
Baseline (Day 1) and Day 21
Change in Self-Perceived Oral Health Status
Baseline (Day 1) and Day 21
Change in Geriatric Oral Health Assessment Index (GOHAI) Score
Baseline (Day 1) and Day 21
Incidence of Upper Respiratory Tract Symptoms
Baseline (Day 1) and Day 21
Change in Salivary Oral Microbiota Composition
Baseline (Day 1) and Day 21
- +1 more secondary outcomes
Study Arms (3)
Essential oil mouthwash
EXPERIMENTALParticipants rinse with 30 mL of an alcohol-free mouthwash containing a blend of tea tree, lemon, and bay laurel essential oils for at least 30 seconds twice daily (morning and evening) after toothbrushing for 21 days.
Chlorhexidine Mouthwash
ACTIVE COMPARATORCommunity-dwelling older adults using an alcohol-free chlorhexidine mouthwash twice daily for 21 days.
Povidone-Iodine Mouthwash
ACTIVE COMPARATORCommunity-dwelling older adults using an alcohol-free povidone-iodine mouthwash twice daily for 21 days.
Interventions
Participants rinse with 30 mL of an alcohol-free mouthwash containing a blend of tea tree, lemon, and bay laurel essential oils for at least 30 seconds twice daily (morning and evening) after toothbrushing for 21 days.
Participants rinse with 30 mL of an alcohol-free chlorhexidine gluconate 2.0 mg/mL mouthwash for at least 30 seconds twice daily (morning and evening) after toothbrushing for 21 days.
Participants rinse with 30 mL of an alcohol-free povidone-iodine mouthwash (available iodine 1 mg/mL) for at least 30 seconds twice daily (morning and evening) after toothbrushing for 21 days.
Eligibility Criteria
You may qualify if:
- Aged 65 years or older.
- Able to communicate verbally.
- No history of asthma, eczema, or allergy to flowers or plants.
- No known hypersensitivity to essential oils, chlorhexidine, or cetylpyridinium chloride.
- No immunocompromising conditions.
- No current use of antihistamines, immunosuppressants, biologic agents, disease-modifying antirheumatic drugs (DMARDs), or corticosteroids that may affect inflammatory responses.
- Willing to participate in the study.
- No use of essential oils or complementary medicine during the past week.
You may not qualify if:
- Younger than 65 years of age.
- Observation period of less than 30 days.
- Major immunodeficiency disorder.
- Dental treatment for periodontal disease or oral infection during the study period.
- History of hypersensitivity to essential oils, chlorhexidine, or povidone-iodine.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
An Nan Hospital, China Medical University, Tainan, Taiwan.
Tainan, 709, Taiwan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Masking Details
- Blocked randomization using a computer-generated list was performed because of the small sample size. One hundred fifty patients were recruited and allocated a ratio of 1:1:1 into one of the following three groups (n = 50 per group). Group A received mouthwash with essential oils (tea tree, lemon, and bay laurel). Group B received Chlorhexidine alcohol-free mouthwash, and Group C received Povidone-iodine alcohol-free mouthwash. A computer-generated list of random numbers using block randomization procedures was utilized to allocate participants.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
October 15, 2026
First Posted
October 21, 2026
Study Start
April 12, 2025
Primary Completion
February 11, 2026
Study Completion
October 12, 2026
Last Updated
October 21, 2026
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be made publicly available because the dataset contains health information from community-dwelling older adults that could compromise participant privacy and confidentiality, and the informed consent obtained did not include provision for public data sharing. De-identified data supporting the published findings may be made available from the corresponding author upon reasonable request, subject to approval by the Institutional Review Board of An Nan Hospital, China Medical University, and in compliance with applicable data protection regulations and institutional data governance policies.